Pharmacokinetic Studies of Tacrolimus in Transplant Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Kidney Transplant RecipientsLiver Transplant Recipients
Interventions
DRUG

Prograf

Brand: Prograf Capsules, 1.0mg Tacrolimus capsules containing white to off white powder equivalent to 1.0 mg of anhydrous tacrolimus are hard gelatin capsules with white opaque body and ivory capsules.

DRUG

Tacrolimus

Generic Hi: Generic tacrolimus Capsules, 1.0mg. Manufacturer to be determined (Aim 1).

DRUG

Tacrolimus

Generic Lo: Generic tacrolimus Capsules, 1.0mg. Manufacturer to be determined (Aim 1).

Trial Locations (2)

45267

The Christ Hospital, Cincinnati

University of Cincinnati, Cincinnati

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

University of Cincinnati

OTHER

NCT01889758 - Pharmacokinetic Studies of Tacrolimus in Transplant Patients | Biotech Hunter | Biotech Hunter